Transcriptional profiling of hematologic malignancies with a low-density DNA microarray

Area of Science:

• Molecular biology
• Genomics
• Biotechnology

Background:

• Limited experience exists with low-density microarrays for gene expression studies.
• High-density microarrays are effective but complex for simultaneous analysis of thousands of genes.

Purpose of the Study:

• To develop and validate an optimized gene expression analysis procedure using a low-density microarray.
• To assess the utility of this procedure in identifying distinct hematologic neoplasias and classifying disease status.

Main Methods:

• Developed a gene expression analysis procedure utilizing a microarray with 538 oligonucleotides.
• Analyzed neoplastic cell lines and whole-blood samples from healthy individuals and patients with hematologic neoplasias.
• Employed hierarchical clustering and Welch t-test with adjusted P values for data analysis.

Main Results:

• The optimized procedure detects 0.2 fmol of mRNA with a linear response over 2 orders of magnitude and <20% CV for replicates.
• Statistically significant gene expression differences were identified between various cell lines and patient groups, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).
• A classification system based on expression data achieved 97% accuracy in predicting healthy versus CLL status from whole-blood samples.

Conclusions:

• Transcriptional profiling of whole-blood samples is feasible without pre-extraction cellular manipulation.
• The developed gene expression analysis procedure effectively identifies statistically significant differences in hematologic neoplasias.
• The procedure enables the construction of a predictive classification system for diseases like CLL using whole-blood samples.